BEAM
Price
$20.24
Change
+$0.41 (+2.07%)
Updated
May 2 closing price
Capitalization
2.04B
10 days until earnings call
RXRX
Price
$5.70
Change
+$0.20 (+3.64%)
Updated
May 2 closing price
Capitalization
2.32B
2 days until earnings call
Ad is loading...

BEAM vs RXRX

Header iconBEAM vs RXRX Comparison
Open Charts BEAM vs RXRXBanner chart's image
Beam Therapeutics
Price$20.24
Change+$0.41 (+2.07%)
Volume$1.78M
Capitalization2.04B
Recursion Pharmaceuticals
Price$5.70
Change+$0.20 (+3.64%)
Volume$19.86M
Capitalization2.32B
BEAM vs RXRX Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. RXRX commentary
May 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and RXRX is a Hold.

Ad is loading...
COMPARISON
Comparison
May 03, 2025
Stock price -- (BEAM: $20.24 vs. RXRX: $5.70)
Brand notoriety: BEAM and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 72% vs. RXRX: 96%
Market capitalization -- BEAM: $2.04B vs. RXRX: $2.32B
BEAM [@Biotechnology] is valued at $2.04B. RXRX’s [@Biotechnology] market capitalization is $2.32B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.17B to $0. The average market capitalization across the [@Biotechnology] industry is $2.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both BEAM and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while RXRX’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • RXRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RXRX is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +3.69% price change this week, while RXRX (@Biotechnology) price change was -0.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.33%. For the same industry, the average monthly price growth was +8.05%, and the average quarterly price growth was -4.75%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

RXRX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.33% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($2.32B) has a higher market cap than BEAM($2.04B). RXRX YTD gains are higher at: -15.680 vs. BEAM (-18.387). BEAM has higher annual earnings (EBITDA): -383.98M vs. RXRX (-426.72M). BEAM has more cash in the bank: 851M vs. RXRX (594M). RXRX has less debt than BEAM: RXRX (108M) vs BEAM (161M). BEAM has higher revenues than RXRX: BEAM (63.5M) vs RXRX (58.5M).
BEAMRXRXBEAM / RXRX
Capitalization2.04B2.32B88%
EBITDA-383.98M-426.72M90%
Gain YTD-18.387-15.680117%
P/E RatioN/AN/A-
Revenue63.5M58.5M109%
Total Cash851M594M143%
Total Debt161M108M149%
TECHNICAL ANALYSIS
Technical Analysis
BEAMRXRX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
87%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 30 days ago
85%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
75%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA287.216.69
+2.38%
Tesla
SPY566.768.29
+1.48%
SPDR® S&P 500® ETF
BTC.X96910.070000417.734380
+0.43%
Bitcoin cryptocurrency
GME27.480.05
+0.18%
GameStop Corp
AAPL205.35-7.97
-3.74%
Apple

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+2.07%
CRSP - BEAM
70%
Closely correlated
+1.38%
NTLA - BEAM
63%
Loosely correlated
+2.31%
RXRX - BEAM
62%
Loosely correlated
+3.64%
DNLI - BEAM
58%
Loosely correlated
+2.37%
VERV - BEAM
57%
Loosely correlated
-5.64%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been closely correlated with CRSP. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if RXRX jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+3.64%
CRSP - RXRX
72%
Closely correlated
+1.38%
BEAM - RXRX
63%
Loosely correlated
+2.07%
NTLA - RXRX
60%
Loosely correlated
+2.31%
ABSI - RXRX
59%
Loosely correlated
N/A
PRME - RXRX
57%
Loosely correlated
-3.45%
More